Clinical updates, including trial initiations, enrollment status and data readouts and publications: Onduo.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acasti, Akari, Axsome, Bluebird, Eiger, Embera, GSK, Imbrium, Kiadis, Maat, Mirum, NGM, Novan, Novartis, Orpheris, Provention, Regenerx, Shattuck, VBI, Vir.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adaptimmune, Arrowhead, Assembly, Daiichi Sankyo, Enanta, Fortress, Idorsia, Janssen, Matinas, Treadwell, Viking.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Carl Zeiss Meditech, Eurofins, Tandem Diabetes Care.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alligator, Applied Molecular Transport, Axcella, Cognition, Cymabay, Durect, Intercept, Mycovia, Oncosec, Onxeo, Redhill, Urogen.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Sight Sciences.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D Pharma, Cardiol, Cerecor, Dermavant, Mycovia, Novartis, Oncolytics, Oncology Venture, Outlook, Silverback.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Acepodia, Ascletis, Aslan, Biontech, Cynata, Novavax, Organicell Regenerative Medicine, Pfizer, Reithera, Revive, Sab, Telix Pharmaceuticals Japan, Trevena, Vanda.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Brainstorm, Viveve.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Bavarian Nordic, Bristol Myers Squibb, Byondis, Immunovant, Ipsen, Krystal, Mereo, Ovid, Takeda, Union.